Fluvoxamine API Manufacturers
compare suppliers & get competitive offers
Country of origin
Established in: 1963
World’s 1st exclusive API distributor
Portfolio of 600+ APIs
>250 clients in Europe
Established in: 2011
MOQ: 100 g
Fast Response and Good Communication
Willingness To Start From Small
Flexible Payment Terms
Replies in a day or 2
Established in: 1968
MOQ: 5 kg
Warehouse stock of nearly all APIs
GMP, GDP and ISO certified
Customisable (small-sized) packages
Established in: 1944
14 international API plant sites
Portfolio of 350+ APIs
Teva is among the world’s largest generic drug/API manufacturers
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Fluvoxamine API 54739-18-3?
- Here you will find a list of producers, manufacturers and traders of Fluvoxamine. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Fluvoxamina , Fluvoxamine , Fluvoxaminum , Fluvoxaminum maleas
- Cas Number:
- DrugBank number:
- Unique Ingredient Identifier:
You can find a short description about Fluvoxamine here. Fluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. Though it is in the same class as other SSRI drugs, it is most often used to treat obsessive-compulsive disorder.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
Fluvoxamine is a type of Serotonin reuptake inhibitors
Serotonin reuptake inhibitors (SRIs) are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various mental health conditions. These medications work by specifically targeting the serotonin transporter protein, inhibiting its function and thereby increasing the concentration of serotonin in the synaptic cleft.
SRIs are commonly prescribed for the management of depression, anxiety disorders, obsessive-compulsive disorder (OCD), and other related conditions. By blocking the reuptake of serotonin, SRIs enhance serotonin neurotransmission, which plays a crucial role in regulating mood, emotions, and cognition.
This class of API includes well-known drugs such as fluoxetine, sertraline, paroxetine, and escitalopram, among others. They are typically administered orally and exhibit good bioavailability, allowing for effective systemic distribution.
The therapeutic effects of SRIs are achieved by modulating the delicate balance of serotonin in the brain. By preventing its reuptake, SRIs ensure that serotonin remains available for longer periods, leading to increased activation of postsynaptic serotonin receptors. This neurochemical modulation results in improved mood, reduced anxiety, and alleviation of related symptoms.
Serotonin reuptake inhibitors are generally well-tolerated, but they may have potential side effects such as nausea, gastrointestinal disturbances, sexual dysfunction, and sleep disturbances. However, these effects are often manageable and vary among individuals.
Overall, serotonin reuptake inhibitors are a crucial class of pharmaceutical APIs widely utilized in the treatment of mental health disorders. Their ability to modulate serotonin levels effectively makes them valuable tools in improving patients' quality of life and well-being.
Fluvoxamine (Serotonin reuptake inhibitors), classified under Central Nervous System Agents
Central Nervous System (CNS) Agents are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that specifically target the central nervous system. The CNS encompasses the brain and spinal cord, playing a vital role in regulating and controlling various bodily functions, including cognition, movement, emotions, and sensory perception. These agents are designed to interact with specific receptors, enzymes, or ion channels within the CNS to modulate neural activity and restore normal functioning.
CNS agents comprise a diverse range of pharmaceutical APIs, including analgesics, anesthetics, antipsychotics, sedatives, hypnotics, anti-epileptics, and antidepressants. Each subcategory addresses distinct neurological disorders and conditions. For instance, analgesics alleviate pain by targeting receptors in the brain and spinal cord, while antipsychotics are employed to manage psychosis symptoms in mental illnesses such as schizophrenia.
The development of CNS agents involves rigorous research, molecular modeling, and extensive clinical trials to ensure safety, efficacy, and specific target engagement. Pharmaceutical companies invest significant resources in identifying novel drug targets, synthesizing new compounds, and optimizing their pharmacological properties. These agents undergo rigorous regulatory evaluations and must adhere to stringent quality standards and guidelines.
Given the prevalence of CNS disorders globally, the market demand for effective CNS agents is substantial. The development of innovative CNS APIs not only improves patient outcomes but also provides valuable commercial opportunities for pharmaceutical companies. Continued advancements in CNS agent research and development hold the promise of groundbreaking therapies that can improve the quality of life for individuals affected by neurological conditions.
Fluvoxamine manufacturers | traders | suppliers
We have 8 companies offering Fluvoxamine produced in 3 different countries.
Get in contact with the supplier of your choice:
- TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
- Shandong Octagon Chemicals Limited from China, product country of origin China
- Duchefa Farma B.V. from Netherlands, product country of origin India
- Teva API from Israel, product country of origin Unknown
- Mehta Api from India, product country of origin India
- Sun Pharma from India, product country of origin India
- Medichem from Spain, product country of origin Unknown
- ZCL Chemicals from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.